Imunon, Inc. (IMNN) financial statements and ratios from SEC XBRL: revenue $500000.00 (TTM), net margin -7179.6%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $500000.00 |
| Net Margin | -7179.6% |
| Price / Book | 2.20 |
| FCF Yield | -114.1% |
| Sector P/E (Healthcare) | 21.7 |
IMNN overview · IMNN earnings · IMNN KPIs · IMNN investor relations · IMNN ownership · IMNN peers · IMNN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.